Skip to NavigationSkip to content

News

According to a piece by Bloomberg, Allergan is looking at options to divest its women’s health unit in a move that could potentially reap about...
AstraZeneca’s biologic R&D unit MedImmune is set to enter a partnership with Israeli drug firm Compugen to develop bi-specific and multi-...
Celgene has had a rough six months, its share price since the beginning of October has dropped from $146 to its present price of $87. Someone has to...
Newly discovered human organ could change our understanding of cancer, GSK pulls out of race for Pfizer Consumer Health, and Roche's blockbuster...
Biotech companies showing faith in their own prospect drug candidates is not an unusual occurrence, some do it to extremes. However, when it happens...
Teva has been spared a sizeable payout to GlaxoSmithKline after a federal judge overturned a US jury verdict demanding that the Israeli firm hand...
In its latest move in the healthcare area, Fujifilm revealed that it will spend $800 million to acquire JXTG’s two cell culturing business, Irvine...
Takeda is considering making a bold move for Shire, after announcing, as per UK regulations, that it may make an approach for the company.
Israeli drug firm CureTech is be sold for the third time in four years, this time to InSight Innovations in a deal with a potential worth of $550...
Roche has been rocked by the revelation that there have been five patient deaths linked to the use of its bispecific factor IXa- and factor X-...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches